Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

Major Biotechs See Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, November 30. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Will Alexion Pharmaceuticals Fight This Activist?

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) shares saw a handy gain early on Friday after the New York Times reported that there might be some increasing activist movement in the stock. ...
Read Full Story »

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

With 2017 coming to an end, investors are wondering how they should be investing for 2018 and beyond. At the start of December, the Dow was up just over 20% ...
Read Full Story »

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Chase Biotechs Higher

The short interest data are out for the most recent settlement date, October 13. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

Third-quarter earnings reporting season is now well under way. So far, things are looking good. The health care sector has yet to see any significant earnings representation, but that will ...
Read Full Story »

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, September 29. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

4 Biotech Stocks to Buy That May See Huge Volatility From Earnings

With the third-quarter earnings reporting season upon us, investors are checking their holdings and research to see just how things are shaping up for stocks they own. One thing is ...
Read Full Story »

Major Biotech, Pharma and FDA Catalysts Coming in October

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a ...
Read Full Story »

Short Sellers Hike Bets in Major Biotechs

The short interest data are out for the most recent settlement date, September 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Hike Bets in Major Biotechs

The short interest data are out for the most recent settlement date, August 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Chesapeake Energy, Lululemon, Oracle, US Steel, Disney, YogaWorks and More

Stocks were indicated to open lower on Monday, but investors know that the major stock indexes remain close to all-time highs. The primary trend that has prevailed for five or ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The short interest data are out for the most recent settlement date, August 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Major Biotechs Send Short Sellers Running for Cover

The short interest data are out for the most recent settlement date, July 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Analyst Has Top Biotech Stocks to Buy as Sector Stays Red Hot

After a wretched 2016, when many of the top biotech companies were hit hard by campaign rhetoric, the industry has roared back to life this year. While nowhere near the ...
Read Full Story »